{{Rsnum
|rsid=4693608
|Gene=HPSE
|Chromosome=4
|position=83320204
|Orientation=plus
|GMAF=0.3375
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=HPSE
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 26.5 | 51.3 | 22.1
| HCB | 71.5 | 23.4 | 5.1
| JPT | 56.6 | 36.3 | 7.1
| YRI | 63.9 | 32.7 | 3.4
| ASW | 71.9 | 24.6 | 3.5
| CHB | 71.5 | 23.4 | 5.1
| CHD | 63.3 | 32.1 | 4.6
| GIH | 41.6 | 47.5 | 10.9
| LWK | 66.4 | 31.8 | 1.8
| MEX | 36.2 | 46.6 | 17.2
| MKK | 55.8 | 37.8 | 6.4
| TSI | 27.5 | 50.0 | 22.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=19406828
|Title=Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation
|OA=1
}}

{{PMID Auto
|PMID=20075159
|Title=Genetic variations in the heparanase gene (HPSE) associate with increased risk of GVHD following allogeneic stem cell transplantation: effect of discrepancy between recipients and donors
|OA=1
}}

{{PMID Auto
|PMID=22276173
|Title=Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern chinese population
|OA=1
}}

{{PMID Auto
|PMID=17095861
|Title=Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of Israel.
}}

{{PMID Auto
|PMID=17611567
|Title=Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
}}

{{PMID Auto
|PMID=24319286
|Title=Modification of heparanase gene expression in response to conditioning and LPS treatment: strong correlation to rs4693608 SNP
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}